Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) EBT Margin (2016 - 2025)

CorMedix's EBT Margin history spans 14 years, with the latest figure at 43.89% for Q4 2025.

  • For Q4 2025, EBT Margin rose 377.0% year-over-year to 43.89%; the TTM value through Dec 2025 reached 48.13%, up 9565.0%, while the annual FY2025 figure was 48.13%, 9199.0% up from the prior year.
  • EBT Margin for Q4 2025 was 43.89% at CorMedix, down from 50.42% in the prior quarter.
  • Across five years, EBT Margin topped out at 215855.54% in Q2 2024 and bottomed at 100538.67% in Q3 2022.
  • The 5-year median for EBT Margin is 24.24% (2024), against an average of 7219.0%.
  • The largest annual shift saw EBT Margin skyrocketed 21239568bps in 2023 before it tumbled -21580433bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 13814.79% in 2021, then plummeted by -100bps to 27656.38% in 2022, then surged by 535bps to 120410.51% in 2023, then crashed by -100bps to 40.11% in 2024, then rose by 9bps to 43.89% in 2025.
  • Per Business Quant, the three most recent readings for CRMD's EBT Margin are 43.89% (Q4 2025), 50.42% (Q3 2025), and 51.21% (Q2 2025).